Carl Zeiss jumps after sales and EBIT beat

Carl Zeiss Meditec AG

09/02/2024 09:20

** Shares in Carl Zeiss Meditec  AFXG.DE  jump around 8%
after the company reported Q1 sales and EBIT above expectations
and reiterated its FY 2023/24 outlook
    ** The German med-tech firm reports Q1 EBIT of 43.5 billion
euros ($47 billion), against the IBES estimate of 38.8 billion
euros, and revenue of 475 million euros (vs IBES estimate of 467
million euros)
    ** Carl Zeiss CEO Markus Weber cites good deliveries,
"significantly improved" production times in its equipment
business in the quarter
    ** Though EBIT in ophthalmic devices came in below
expectations, this was offset by better-than-expected EBIT in
microsurgery, with strong sales growth in EMEA, J.P.Morgan says 
    ** If gains hold, the stock will see its best day since
March 16, 2022, when it closed 9% higher


($1 = 0.9276 euros)

 (Eva Orsolya Papp)
 ((evaorsolya.papp@thomsonreuters.com))